Anti-Infectious Drugs Products

Highlight

• Local Manufacture API ( Active Pharmaceutical ingredients )
• Generic medicine and bioequivalent to the reference medicine

Indication

For the treatment of chronic hepatitis B virus infection in adults.

Highlight

• Broad-spectrum antifungal (triazole class)
• Fungicidal activity against Aspergillus spp.
• Effective for severe and life-threatening fungal infections
• Option for patients intolerant or refractory to other antifungals
• Available in IV formulation (hospital setting)
• Well-established efficacy in invasive fungal infections

Indication

Invasive aspergillosis; candidemia in non-neutropenic patients; serious invasive Candida infections (incl. C. krusei); esophageal candidiasis; serious fungal infections caused by Scedosporium apiospermum and Fusarium spp.; for patients intolerant or unresponsive to other therapies.

Highlight

• Advanced biologic treatment option
• Proven biosimilar quality, comparable to the innovator
• Affordable price point versus the originator product
• Targeted anti-TNFα therapy for inflammatory diseases
• Wide range of approved indications across rheumatology, gastroenterology and dermatology

Indication

Rheumatoid arthritis; Crohn's disease; ankylosing spondylitis; psoriatic arthritis; ulcerative colitis; plaque psoriasis.

Highlight

• IDSA Recommendation for 1st line therapy invasive candidiasis
• More effective than fluconazole in preventing fungal infection in patients undergoing a bone marrow transplant

Indication

Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis & Abscesses Candidiasis Esofagus, Profilaksis for patient candidiasis with stem cell Transplantation.